← Back
Data updated: Mar 10, 2026
LYPHOMED
Pharmaceuticals
LYPHOMED is a generic drug manufacturer with 7 FDA-approved products.
1977
Since
7
Drugs
-
Trials
42
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
LIDOCAINE HYDROCHLORIDE 2025-10-02
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-09-26
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-27
Manufacturing (CMC)
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
LIDOCAINE HYDROCHLORIDE 2025-08-22
Labeling
DIPHENHYDRAMINE HYDROCHLORIDE 2025-08-22
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
METOCLOPRAMIDE HYDROCHLORIDE 2025-08-01
Labeling
LIDOCAINE HYDROCHLORIDE 2025-07-29
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (7)
Company Info
- First Approval
- 1977-03-14
- Latest
- 1991-07-31
- Applications
- 7